Evidence map›Paper›PMID 35008587›Full record

ArticleInternational journal of molecular sciences2021

The Antibiotic Fosfomycin Mimics the Effects of the Intermediate Metabolites Phosphoenolpyruvate and Glyceraldehyde-3-Phosphate on the

Teresa Gil-Gil, Luz Edith Ochoa-Sánchez, José Luis Martínez

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Tripartite Loops Reverse Antibiotic Resistance.Molecular biology and evolution · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Fosfomycin Resistance Evolutionary Pathways ofInternational journal of molecular sciences · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Teresa Gil-GilCentro Nacional de Biotecnología, CSIC, Darwin 3, 28049 Madrid, Spain.ORCID 0000-0003-0136-3965
Luz Edith Ochoa-SánchezCentro Nacional de Biotecnología, CSIC, Darwin 3, 28049 Madrid, Spain.
José Luis MartínezCentro Nacional de Biotecnología, CSIC, Darwin 3, 28049 Madrid, Spain.ORCID 0000-0001-8813-7607
Centro Nacional de Biotecnología · ES

Funding

Comunidad de Madrid S2017/BMD-3691Instituto de Salud Carlos III RD16/0016/0011MCIN/AEI /10.13039/501100011033 PID2020-113521RB-I00
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AminoglycosidesAnti-Bacterial AgentsBacterial ProteinsDrug Resistance, Multiple, BacterialFosfomycinGlyceraldehyde 3-PhosphatePhosphoenolpyruvateStenotrophomonas maltophiliaTranscriptomeAminoglycosidesAnti-Bacterial AgentsBacterial ProteinsFosfomycinGlyceraldehyde 3-PhosphatePhosphoenolpyruvateadjuvantfosfomycin resistanceglyceraldehyde-3-phosphatephosphoenolpyruvateStenotrophomonas maltophiliatranscriptomics

Identifiers

PMID35008587
PMCPMC8745565
OpenAlexW4200268373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.